April 30th 2025
Novavax continues working with FDA, but case could signal a shift in broader vaccine procedures.
April 10th 2025
Global Healthy Living Foundation urges CDC to simplify shared decision-making and risk-based guidance as coverage rates drop.
March 20th 2025
ACP, medical groups, and Sen. Cassidy challenge the Louisiana Surgeon General’s decision.
Public health experts describe the latest on measles cases in Texas and broader concerns about vaccinations.
March 13th 2025
Weldon has been critical of vaccine safety and efficacy.
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Pfizer chief says COVID-19 booster likely needed
The CEO of the drug company says that a booster followed by annual vaccinations will likely be needed to defeat the pandemic.
Drug advisory committee needs more time on Johnson and Johnson vaccine decision
ACIP delayed a vote on lifting a federal pause on the single-dose COVID-19 vaccine.
FDA, CDC call for pause on Johnson and Johnson COVID-19 vaccine
U.S. regulators is taking a pause on administering the vaccine while experts study a small number of blood clots.
CDC: Fully vaccinated people can travel
Travel restrictions have been loosened for those who’ve been vaccinated against COVID-19.
FDA amends Moderna COVID-19 vaccine EUA
The move clarifies the number of doses that can be administered from each vial and approves larger vials.
Coronavirus case numbers in the United States: April 5, 2021 update
Data from the Coronavirus Resource Center at Johns Hopkins University and the Centers for Disease Control.
AMA calls for practices to play greater part in COVID-19 vaccinations
AMA President Susan R. Bailey, MD, says it is time for physicians to take a more commanding position in the vaccination effort.
Pfizer COVID-19 vaccine shows promise in adolescents
An analysis by the drug maker shows the vaccine may be more effective in adolescent patients than in adults.
HHS to make COVID-19 vaccines more available to older adults, disabled people
Agencies will provide about $100 million in grants to aging and disability networks across the country.
AstraZeneca releases updated COVID-19 vaccine data
The updated data was released after U.S. regulators questioned a release earlier this week.
Half opposed COVID-19 vaccine in late 2020
An online survey conducted in late-2020 shows what drove vaccine hesitancy.
Updated: AstraZeneca COVID-19 vaccine candidate proves effective in Phase III trial
The vaccine candidate met the primary efficacy endpoint in preventing COVID-19 in an interim analysis.
CMS increasing payment for COVID-19 vaccinations
The national average payment rate will increase by about $12 for administering each dose of the vaccines.
Study: Physician consultation leads to pandemic vaccination
A look at data from the swine flu pandemic shows that physicians who talk vaccination with their doctor often get the shot.
Five takeaways from Biden’s big COVID-19 week
President Joe R. Biden marked the anniversary of the onset of the COVID-19 coronavirus pandemic with a flood of action.
BREAKING: Biden announces purchase of 100 million Johnson & Johnson COVID-19 vaccine doses
The new doses will spring from the production partnership of Johnson & Johnson and Merck.
CDC releases post-vaccination COVID-19 recommendations
Those who have been fully vaccinated can safely visit other vaccinated people and small groups of those who have yet to get the jab.
Building confidence in vaccines: A free MJH Life Sciences COVID-19 Coalition webinar
The next MJH Life Sciences COVID-19 Coalition webinar will focus on building confidence in vaccines.
Deal reportedly struck for Merck to help manufacture Johnson & Johnson COVID-19 vaccine
Multiple news organizations report that the White House has brokered the unusual deal.
Free MJH Life Sciences COVID-19 Coalition webinar to focus on vaccines
FDA grants Johnson & Johnson COVID-19 vaccine EUA
The single-dose vaccine is the third granted emergency use authorization in an effort to end the COVID-19 coronavirus pandemic.
Coronavirus: Johnson & Johnson vaccine shows high effectiveness
Documents released by the FDA before they consider an EUA for the single-dose vaccine show that it is effective against COVID-19.
Coronavirus: Pfizer to ship 13 million vaccine doses a week to U.S.
The drug maker expects to deliver 120 million doses of its COVID-19 vaccine by the end of March.
Free COVID-19 law, ethics webinar tomorrow
The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar tomorrow at 6 p.m. EST.
Poll: Americans expect COVID-19 disruptions to continue well into 2021
More than half of Americans expect disruptions to persist past the middle of this year, a jump from late-December’s responses.
Free webinar to focus on law, ethics of COVID-19 vaccinations
The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar at 6 p.m. EST, Feb. 24.
ACP supports legislation increasing healthcare access, combatting COVID-19 pandemic
In a pair of letters to congressional committees, the organization extolls the benefits of provisions in upcoming COVID relief legislation.
Coronavirus: Primary care physicians taking part in vaccine effort, many await supply
Primary care physicians are getting involved with the vaccination effort, but only 19 percent say they’re currently administering the shots.
Health care associations produce pro-COVID vaccine PSA
The public service announcement urges Americans to be vaccinated against COVID-19.
Novavax begins rolling review of COVID-19 vaccine candidate
The drug maker has started reviews with regulatory agencies across the world.